Therefore, despite the promise that flavan-3-ols show as novel cholinesterase inhibitors for the treatment of AD, they could be evaluated in the context of preventative medication, possibly being used to mitigate the negative effects of exposure to AD risk factors. The gene discussed is BCHE; the disease is Alzheimer disease.